Exploring Unconventional Plant-Derived Metabolites for Glycemic Control: the Case of Pomegranate

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

September 30, 2024

Conditions
Prediabetes
Interventions
DIETARY_SUPPLEMENT

EPS supplement intervention

31 healthy individuals, male and female, were recruted at one family health unit, and randomly assigned to the intervention group, and were given for 12 weeks of one daily dose of 1.5 g powdered capsules of EPS.

DIETARY_SUPPLEMENT

Placebo

29 healthy individuals, male and female, were recruted at one family health unit, and randomly assigned to the placebo group, and were given for 12 weeks of one daily dose of placebo.

Trial Locations (1)

1749-024

Lusofona University, Lisbon

All Listed Sponsors
collaborator

Universidade Lusófona de Humanidades e Tecnologias

UNKNOWN

lead

Regina Menezes

OTHER

NCT06659523 - Exploring Unconventional Plant-Derived Metabolites for Glycemic Control: the Case of Pomegranate | Biotech Hunter | Biotech Hunter